On June 9th, Jean-Pierre Vacher,  Host of the « Bourse et Valeurs » (« Market & stocks ») segment on French TV station TLM, interviewed Dr. Olivier Soula, Deputy General Manager and R&D Director at Adocia. This was an opportunity to comment Adocia latest news. You may access the video here . Please note
Dear Shareholders, Adocia was delighted to present you its news and meet you during the Biotech Agora Event last June 19th, 2018 at Paris. A success: you were more than 70 attendees. Thank you ! to receive the PPT Presentation of this conference, please contact: contactinvestisseurs@adocia.com 
Biotech Agora’s purpose is to familiarize investors with companies offering breakthrough innovations in the field of life sciences. Next June 19th, 2018, Biotech Agora welcomes Adocia to present its business model, BioChaperone® Technology, pipeline, partnerships then finance and news flow. Come and meet the Adocia management team ! https://www.biotech-agora.com/en/nos-evenements/    
Press Release, June 1st 2018: Adocia and Tonghua Dongbao Announce Global Supply Agreements for Insulin Lispro and Insulin Glargine. Tonghua Dongbao will manufacture and supply insulin glargine and insulin lispro to Adocia worldwide, excluding China. Adocia Press Release June 1st, 2018         These agreements expand the previously announced strategic alliance between both
June 4th-7th, Gerard Soula, Adocia President and CEO, and Stephen Daly, General US Manager will attend the 2018 BIO International Convention at Boston – US. At this occasion, Gérard Soula will present Adocia: Monday, June 4th, 2:45 PM, Boston Convention and Exhibition Center, Theater 4 http://convention.bio.org/
May 3rd at 3PM CET: Adocia to hold conference call in regard to the Strategic Alliance for BioChaperone® Combo and BioChaperone® Lispro in China with Tonghua Dongbao. A conference call in French with the Company’s Executive Management is planned for Thursday May 3rd, 2018 at 6 PM (CET) A transcript in English and in French
This year, Adocia will welcome shareholders having registered their shares in Lyon, at Château de Montchat. To know more about shareholders’ meeting, please see the Press release contact contact investisseurs Adocia    
On April 16th, 2018, Gérard Soula – Adocia CEO – was interviewed by Didier Testot on Web TV “La bourse et la vie” Chanel.   To see the interview (French only) : Interview    
Adocia Business Development team is attending the Bio-Europe Spring Event 2018 ! This unmissable business event gathers biotech companies, large and midsize pharmaceutical companies, investors and other industry experts: https://ebdgroup.knect365.com/bioeurope-spring.